Distribuirea grasimii corporale - Waist-to-Hip-Ratio (WHR)Cu cit este mai mare BMI cu atit riscul de infarct miocardic si accident vascular cerebral creste. Studiile internationale arata ca factorul de risc = distribuirea grasimii corporale - Waist-to-hip-Ratio (WHT) care este o mai buna masurare a riscului de infarct si accident vascular cerebral. La barbati: distribuirea grasimii corporale regiunea abdomenului, (forma de mar) cu un risc marit de boli cardiovasculare Distribuirea grasimii corporale - Waist-to-hip-Ratio (WHT)
La femei: distribuirea grasimii corporale pe fese si coapse - obezitate gluteo-femurala, (forma de para) cu un risc marit de boli cardiovasculare Pentru distribuirea grasimii corporale (WHR) se caracerizeaza = Raportul dintre Distribuirea grasimii corporale a taliei si distribuirea grasimii corporale a soldului - La barbati: WHR este mai mare de 1 = forma de mar - La femei: WHR este mai mare de 0,85 = forma de para - Riscul circumferintei abdominale incepe la barbati cu talia de 94 cm, iar la 102 cm se afla in zona de pericol, cu marirea valorilor de trigliceride, si cresterea colesterolului in singe, care sint facori de risc, infarct miocardic si accident vascular cerebral
- Riscul circumferintei abdominale incepe la femei cu talia de 80 cm, iar la 88 cm se afla in zona de pericol, cu marirea valorilor de trigliceride, si cresterea colesterolului in singe, care sint facori de risc, infarct miocardic si accident vascular cerebral
Reducerea de: Hemoglobina glicozilata HbA1cTesutul adipos secreta: Citokine (Mediatori inflamatorii), un factor implicat in procesul de ateroscleroza ca factor de agregare plachetara, factor regulator al tensiunii si factor regulator al metabolizmului cu hormonul: Adiponectina un factor protector cardiovascular si un biomarker de risc.Cu aparatul de masura a greutatii corporale si circumferinta abdominala se constata riscul bolilor metabolice: diabet zaharat tip 2, afectiuni cardiovasculare si accident vascular cerebral, recomandabil: Vitamina E Forte 400 UI.
La barbati cine are indexul masei corporale BMI mai mare de 30 kg/m2(Biomarker de sindrom metabolic) si o circumferinta abdominala mai mare de 102 cm este afectat grav.La femei riscul creste deja la o circumferinta abdominala de 88 cm este afectat grav de a primi boli metabolice: diabet zaharat tip 2, afectiuni cardiovasculare si accident vascular cerebral, recomandabil: Vitamina E Forte 400 UI.Cu 4 ore de sport, pe saptamina si un consum zilnic mai mic de 30 % de acizi grasi, dintre care acizi grasi saturati mai putin de 10 % si 15 g/1000kcal-fibra dietetica (dietary fiber), recomandabil: Chitosan Plus, Cura de Slabire si
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tesut adipos inainte de cura de slabire | Tesut adipos dupa cura de slabire |
![]() |
![]() |
| Bibliografie-Referinte: |
![]() |
1. Kulharni K, Mgbere O, Kouamou G, Ohia
SE, Bagchi D, Bagchi M, Regulation of Rat Brain Neuropeptide and Concentration
by Hydroxycitric Acid,
In Vitro, Experimental Biology Meeting, Volume 19, No. 4: abs 310.8, April
2005.
2. Downs BW, Bagchi M, Subbaraju GV,
Shara MA, Preuss HG, Bagchi D. Bioefficacy
of a novel calcium-potassium salt of (-)-hydroxycitric acid. InterHealth
Research Center, Benicia, CA, USA. Mutat Res. 2005 Nov 11;579(1-2):149-62.
Epub 2005 Aug
1.
3. Leibowitz SF, Alexander JT, Hypothalamic
Serotonin in Control of Eating Behavior, Meal Size, and Body Weight, Biological
Psychiatry, 44:851-864, 1998.
4. Heymsfield SB, Allison DB, Vasselli
JR, Pietrobelli A, Greenfield D, Nunez C: Garcinia
cambogia (Hydroxycitric Acid) as a Potential Antiobesity Agent: a randomized
controlled trial. JAMA 1998; 280(18):1596-1600.
5. Turek FW, Joshu C, Kohsaka A, Lin
E, Ivanova G, McDearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR,
Eckel
RH, Takahashi JS, Bass J. Obesity
and Metabolic Syndrome in Circadian Clock Mutant Mice. Science. 2005 Apr
21;
6. Bass J, Turek FW. Sleepless
in America: a pathway to obesity and the metabolic syndrome Arch Intern
Med. 2005 Jan 10;165(1):15-6.
7. Vorona RD, Winn MP, Babineau TW,
Eng BP, Feldman HR, Ware JC. Overweight
and obese patients in a primary care population report less sleep than
patients with a normal body mass index. Division of Sleep Medicine,
Departments of Internal Medicine, Eastern Virginia Medical School, Norfolk,
VA 23507, USA. Arch Intern Med. 2005 Jan 10;165(1):25-30.
8. Ohia SE, Opere CA, LeDay AM, Bagchi
M, Bagchi D, Stohs SJ, Safety and Mechanism of Appetite Suppression by
a Novel Hydroxycitric Acid Extract (HCA-SX), Molecular and Cellular Biochemistry,
238:89-103, 2002.
9. Ohia SE, Awe SO, LeDay AM, Opere
CA, Bagchi D, Effect of Hydroxycitric Acid on Serotonin Release from Isolated
Rat
Brain Cortex, Research Communications in Molecular Pathology and Pharmacology,
109:210-216, 2001.
10. Preuss HG, et al. Effect of hydroxycitric
acid on weight loss, body mass index and plasma leptin levels in human subjects.
FASEB J 2002;16:(5):A1020
- Sullivan C, Triscari J: metabolic regulation as a control for lipid disorders.
I. Influence of (-)-hydrocycitrate on experimentally induce obesity in the rodent.
Am J Clin Nutr 1977;30(5):767-776.
- "Effectiveness of a Garcinia cambogia and natural caffeine combination
in weight loss: a double-blind placebo-controlled pilot study" Rothacker
DQ, Waitman BE. Int J Obes. 1997;21(suppl 2):53
11. Kazakoff K, Cardesa T, Liu J, Adrian
TE, Bagchi D, Bagchi M, Birt DF, Pour PM, Effects of Voluntary Physical Exercise
on High-Fat Diet-Promoted Pancreatic Carcinogenesis in the Hamster Model, Nutrition
and Cancer, 26:265-279, 1996.
12. Loe YC, Bergeron N, Rodriguez N,
Schwarz J-M, Gas Chromatography/Mass Spectrometry Method to Quantify Blood
Hydroxycitrate Concentration, Analytical Biochemisty, 292:148-154, 2001.
13. McCarty, M.F. (1995) "Inhibition
of Citrate Lyase May Aid Aerobic Endurance." Medical Hypotheses 45, 247-254
- Watson, J.A., Fang, M., and Lowenstein, J.M. (1969) "Tricarballylate and
Hydroxycitrate: Substrate and Inhibitors of ATP:Citrate Oxaloacetate Lyase." Arch.
Biochem. Biophys. 135, 209-217
- Brekhout TA, Havekes LM, Pearce NJ et al: The effect of HCA on the activity
of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-Co-A reductase
levels in the human hepatoma cell line Hep G2. Biochem J 15 1990;272(1):181-186.
14. Sullivan AC, Triscari J, Spiegel
JE: Metabolic regulation as a control for lipid disorder. II. Influence of
(-)-hydroxycitrate on genetically and experimentally induced hypertriglyceridemia
in the rat. Am J Clin Nutr 1977; 30(5):777-784.
15. Schwarz JM, Chen TW & Linfoot
P: Effect of Hydroxycitrate on hepatic de novo lipogenesis, gluconeogenesis
and glucose production in obese hyperinsulinemic subjects (abstract). Circulation
1999; 100(18 suppl 1):I-196-I-197.
- Sener A, Malaisse WJ: Hexose metabolism in pancreatic islets. Effect of HCA
upon fatty acid synthesis and insulin release in glucose-stimulated islets. Biochimie
1991;73(10): 1287-1290.
16. Thom E. Hydroxycitrate (HCA)
in the treatment of obesity [abstract]. Paper presented to the European Conference
on Obesity, Barcelona, 1996. Int J Obes 1996; 20: 111.
17. Vincent JB. The biochemistry
of chromium. J. Nutri. 2000; 130:715-718.
- Lukaski HC. Chromium
as a supplement. Annu Rev Nutr. 1999;19:279-302.
Press RI et al. The effect of chromium picolinate on serum cholesterol and apolipoprotein
fractions in human subjects. West. J. Med. 1990; 152:41-45.
- Anderson RA, Polansky MM, Bryden NA, et al. Chromium supplementation of human
subjects: effects on glucose, insulin, and lipid variables. Metabolism 1983;
32: 894-899.
- Evans GW. The effect of chromium picolinate on insulin controlled parameters
in humans. Int J Biosoc Med Res 1989; 11: 163-180.
- Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA. Chromium
homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol.
1999;13(1-2):57-61.
- Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J, Feng J. Elevated
intakes of supplemental chromium improve glucose and insulin variables in individuals
with type 2 diabetes. Diabetes. 1997;46(11):1786-1791.
18. Anderson RA. Effects
of chromium on body composition and weight loss. Nutr Rev. 1998;56(9):266-270.
- Hoeger WW. et al. Four-week supplementation with a natural dietary compound
produces favorable changes in body composition. Adv. Ther. 1998; 15:305-314.
- Kaats GR, Fischer JA, Blum K. The effects of chromium picolinate supplementation
on body composition in different age groups [abstract]. Am Aging Assoc Abstr
1991; 21: 138.
- Stearns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium (III) accumulation
in humans from chromium dietary supplements. FASEB J 1995; 9: 1650-1657.
- Anderson RA. Effects of chromium on body composition and body weight. Nutr
Rev 1998; 56: 266-270.
- Schardt, D. and Schmidt, S. (1996) "Supplement Watch: Chromium." Nutrition
Action Healthletter, May, 10-11
- Kaats GR. et al. A randomized double blind placebo controlled study of the
effects of chromium picolinate supplementation on body composition. Curr. Ther.
Res. Clin. Exp. 1998; 59:379-388.
- Kaats GR. et al. Effects of chromium picolinate supplementation on body composition:
A randomized double blind placebo controlled study. Curr. Ther. Res. 1996; 57:747-756.
19. Grant KE, Chandler RM, Castle AL,
Ivy JL. Chromium and exercise training: effect on obese women. Med Sci Sports
Exerc 1997; 29: 992-998.
- Lukaski HC, Bolonchuk WW, Siders WA, Milne DB. Chromium
supplementation and resistance training: effects on body composition, strength,
and trace element status of men. Am J Clin Nutr. 1996;63(6):954-965.
- Campbell WW, Beard JL, Joseph LJ, Davey SL, Evans WJ. Chromium
picolinate supplementation and resistive training by older men: effects on
iron-status and hematologic indexes. Am J Clin Nutr. 1997;66(4):944-949.
- Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect
of chromium supplementation and exercise on body composition, resting metabolic
rate and selected biochemical parameters in moderately obese women following
an exercise program. J Am Coll Nutr. 2001;20(4):293-306.
20. Anderson RA, Cheng N, Bryden N,
et aI. Beneficial effects of chromium for people with diabetes. Diabetes, May,
1966;45 (supple 2]: Abstract 1263.
- Abraham AS, Brooks BA and Eylath U. The effects of chromium supplementation
on serum glucose and lipids in patients with and without non-insulin dependent
diabetes. Metabolism, July 1992; 7:768.
- Anderson RA, Polansky MM, Bryden NA, et. al. Supplemental-chromium effects
on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming
controlled low-chromium diets. Am J Clin Nutr, 1991; 54:909-16.
- Anderson RA and Kozlowsky AS. Chromium intake, absorption and excretion of
subjects consuming self-selected diets. American J of Clinical Nutrition, 1985;
41 :1177.
- Evans GW, “Chromium picolinate is an efficacious and safe supplement”.
Int J Sport Nutr 3, 117-122, 1993
21. Davies KM, Heaney RP, Recker RR,
Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S. Calcium
intake and body weight. J Clin Endocrinol Metabol. 2000;85(12):4635-4638.
-
Zemel
MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation
of adiposity by
dietary calcium. FASEB J. 2000;14(9):1132-1138.
-
Lin YC, Lyle RM,
McCabe LD, McCabe GP, Weaver CM, Teegarden D. Dairy
calcium is related to changes in body composition during a two-year exercise
intervention
in young women. J Am Coll Nutr. 2000;19(6):754-760.
- Dietary Calcium Reduces Body Weight Heaney, R.P., Davies, K.M., Barger-Lux,
M.J., "Calcium and Weight: Clinical Studies," Journal of the American
College of Nutrition, 21(2), 2002, pages
152S-155S.
- Shi H et al. 2001. Effects
of dietary calcium on adipocyte lipid metabolism and body weight regulation in
energy-restricted aP2-agouti transgenic mice. FASEB J 5:291-293.
- Regulation
of adiposity and obesity risk by dietary calcium: mechanisms and implications.
Zemel MB. 2002. J Am Coll Nutr 21: 146S-151S.
22. Zemel
MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation
of adiposity by
dietary calcium. FASEB J. 2000;14(9):1132-1138.
- Regulation of adiposity
by dietary calcium. Zemel MB et al. 2000. FASEB J 14:1132-1138.
23. Shi H et al. 2001. Effects
of dietary calcium on adipocyte lipid metabolism and body weight regulation
in
energy-restricted aP2-agouti transgenic mice. FASEB J 5:291-293.
24. Davies KM, Heaney RP, Recker RR,
Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S. Calcium
intake and body weight. J Clin Endocrinol Metabol. 2000;85(12):4635-4638.
25. Regulation
of adiposity and obesity risk by dietary calcium: mechanisms and implications.
Zemel MB. 2002. J Am Coll Nutr 21: 146S-151S.
26. Lin YC, Lyle RM,
McCabe LD, McCabe GP, Weaver CM, Teegarden D. Dairy
calcium is related to changes in body composition during a two-year exercise
intervention
in young women. J Am Coll Nutr. 2000;19(6):754-760.
27. Dietary Calcium Reduces Body Weight
Heaney, R.P., Davies, K.M., Barger-Lux,
M.J., "Calcium and Weight: Clinical Studies," Journal of the American
College of Nutrition, 21(2), 2002, pages
152S-155S.
28. Whelton PK, He J, Cutler JA, et
al. Effects of oral potassium on blood pressure. Meta-analysis of randomized
controlled clinical triglyceride
trials. JAMA. 1997; 277:1624-1632.
29. Bagchi M, Zafra-Stone S, Sen CK,
Sashwati R, Bagchi D, DNA
Microarray Technology in the Evaluation of Weight Management Potential of a
Novel Calcium-Potassium Salt of (—)-Hydroxycitric Acid, Toxicology
Mechanisms and Methods 16:129-135,
2006.
30. Roy S, Rink C, Khanna S, Phillips
C, Bagchi D, Bagchi M, Sen CK, Body
Weight and Abdominal Fat Gene Expression Profile and Response to a Novel Hydroxycitric
Acid-Based Dietary Supplement, Laboratory of Molecular Medicine, Department
of Surgery, The Ohio State University Medical Center, Columbus, OH 43210, USA.
Gene
Expr. 2004;11(5-6):251-62.
31. Shara M, Ohia SE, Schmidt RE, Yasmin
T, Zardetto-Smith A, Kincaid A, Bagchi M, Chatterjee A, Bagchi D, Stohs SJ.
Physico-chemical properties of a novel (-)-hydroxycitric acid extract and its
effect on body
weight, selected organ weights, hepatic lipid peroxidation and DNA fragmentation,
hematology and clinical chemistry, and histopathological changes over a period
of 90 days. Department of Pharmacy Sciences, School of Pharmacy and Health
Professions, Creighton University Medical Center, Omaha, NE 68178, USA. Mol
Cell Biochem. 2004 May;260(1-2):171-86.
32. Soni MG, Burdock GA, Preuss HG,
Stohs SJ, Ohia SE, Bagchi D. Safety
assessment of (-)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium
salt. Burdock Group, 780 US Highway 1, Suite 300, Vero Beach, FL 32962,
USA. msoni@burdockgroup.com Food Chem Toxicol. 2004 Sep;42(9):1513-29.
33. "chitosan is a revolutionary
discovery that reduces fat, lowers triglycerides helps raise good cholesterol
and controls appetite naturally," says Dr.Arnold Fox, a noted Beverly
Hills, Calif., cardiologist and author of the new book: The Fat Blocker Diet,
St. Martin's
Press.
34. Dr. Elizabeth Muss, assistant clinical
professor at Cornell University Medical College in Ithaca, N.Y., says: "chitosan
is a highly effective, safe, simple, and inexpensive
way to lose fat.


|
Anti-Aging-Systeme
© 2008
|
Design by NB |